Skip to main content

Gene Editing in Bioinformatics - From Data to Discovery

$299.00
How you learn:
Self-paced • Lifetime updates
Toolkit Included:
Includes a practical, ready-to-use toolkit containing implementation templates, worksheets, checklists, and decision-support materials used to accelerate real-world application and reduce setup time.
Who trusts this:
Trusted by professionals in 160+ countries
Your guarantee:
30-day money-back guarantee — no questions asked
When you get access:
Course access is prepared after purchase and delivered via email
Adding to cart… The item has been added

This curriculum spans the technical and operational complexity of a multi-year bioinformatics initiative, comparable to establishing an internal genome analysis platform within a research hospital or biotech firm, where infrastructure, accuracy, compliance, and scalability are managed across diverse sequencing applications and regulatory environments.

Module 1: Foundations of Genomic Data Infrastructure

  • Select and configure a high-performance computing cluster optimized for handling whole-genome sequencing data with burst capacity for peak analysis loads.
  • Implement version-controlled data pipelines using Git and CI/CD workflows to ensure reproducibility across multiple sequencing runs.
  • Design a tiered storage architecture integrating hot storage (SSD) for active analysis and cold storage (tape or object storage) for archival compliance.
  • Establish metadata standards (e.g., MIAME or MINSEQE) for sample annotation to ensure cross-project interoperability and audit readiness.
  • Integrate checksum validation at every data ingestion point to detect corruption during transfer from sequencing facilities.
  • Deploy containerized execution environments (e.g., Singularity or Docker) to maintain software dependency consistency across heterogeneous systems.
  • Negotiate data transfer protocols with external sequencing providers to minimize latency and ensure secure transmission via SFTP or Aspera.
  • Define retention policies for raw FASTQ files, intermediate BAMs, and final VCFs in alignment with institutional and regulatory requirements.

Module 2: Preprocessing and Quality Control of NGS Data

  • Configure Trimmomatic or Cutadapt parameters to remove adapter sequences and low-quality bases based on per-project Phred score distributions.
  • Implement automated FastQC reporting with threshold-based alerting for deviations in base quality, GC content, or sequence duplication rates.
  • Develop custom scripts to detect and filter PCR duplicates in amplicon-based sequencing data when reference alignment is ambiguous.
  • Adjust quality trimming strategies based on sequencing platform (Illumina vs. Oxford Nanopore) and library preparation method.
  • Integrate MultiQC to aggregate QC metrics across hundreds of samples for centralized monitoring and batch effect detection.
  • Validate read alignment rates and coverage uniformity before proceeding to variant calling, flagging samples with <15x mean coverage.
  • Apply host genome subtraction pipelines for metagenomic or cell-free DNA datasets to enrich for target organism reads.
  • Document and version all preprocessing decisions in a pipeline log for auditability during regulatory submissions.

Module 3: Reference Genome Selection and Alignment Strategies

  • Evaluate the use of GRCh38 versus alternate assemblies (e.g., T2T-CHM13) based on project goals involving complex genomic regions.
  • Select alignment algorithms (BWA-MEM, Bowtie2, minimap2) based on read length, error profile, and computational efficiency requirements.
  • Index reference genomes with appropriate block sizes to balance memory usage and alignment speed in production environments.
  • Implement splice-aware alignment using STAR or HISAT2 for RNA-seq datasets with fusion gene detection objectives.
  • Manage reference version drift by pinning genome builds and annotation files to specific project instances.
  • Configure alignment parameters to handle structural variants, such as increasing seed length for improved sensitivity in repetitive regions.
  • Validate alignment accuracy using known control samples (e.g., NA12878) and benchmark against GIAB truth sets.
  • Optimize alignment parallelization across compute nodes to minimize turnaround time without exceeding memory limits.

Module 4: Variant Calling and Genotype Refinement

  • Choose between GATK HaplotypeCaller, FreeBayes, or DeepVariant based on project scale, variant type, and required precision.
  • Apply joint calling across cohorts to improve genotype accuracy, especially for low-frequency variants in population studies.
  • Implement VQSR (Variant Quality Score Recalibration) with project-specific training resources when sufficient variant counts are available.
  • Use hard filtering thresholds (QD < 2.0, FS > 60.0) when VQSR is infeasible due to small cohort size.
  • Integrate germline and somatic callers separately, using Mutect2 for tumor-normal pairs with panel of normals.
  • Refine indel calls using local reassembly and realignment, particularly in homopolymer regions prone to sequencing errors.
  • Validate variant calls with orthogonal methods (e.g., Sanger sequencing) for high-impact variants prior to functional interpretation.
  • Track and document false positive rates across different genomic contexts (e.g., high GC, segmental duplications).

Module 5: Functional Annotation and Pathogenicity Assessment

  • Select annotation databases (e.g., ClinVar, gnomAD, COSMIC, dbSNP) based on clinical relevance and population specificity.
  • Configure ANNOVAR or VEP to prioritize loss-of-function, missense, and splice-site variants using ACMG/AMP guidelines.
  • Integrate CADD or REVEL scores to rank variants by predicted deleteriousness in absence of clinical evidence.
  • Resolve conflicting interpretations in ClinVar by reviewing submission history and evidence codes from submitters.
  • Apply tissue-specific expression data from GTEx to filter variants in genes not expressed in the relevant biological context.
  • Flag variants in pharmacogenomic genes (e.g., CYP2D6, TPMT) for additional review when planning clinical reporting.
  • Update annotation databases on a quarterly schedule and reprocess prior results when major revisions occur.
  • Implement custom filters to exclude variants in pseudogenes or paralogous regions with high sequence similarity.

Module 6: CRISPR Off-Target Analysis and Guide Design

  • Use Cas-OFFinder or COSMID to scan reference genomes for potential off-target sites with up to 4 mismatches and bulges.
  • Adjust PAM specificity settings based on nuclease variant (e.g., SpCas9 vs. HiFi Cas9) during guide RNA design.
  • Incorporate chromatin accessibility data (e.g., ATAC-seq) to prioritize guides in open genomic regions for higher editing efficiency.
  • Rank candidate guides using integrated scores from Doench 2016 or Azimuth models trained on empirical editing outcomes.
  • Design blocking primers or modified sgRNAs to suppress editing at known off-target loci with high similarity.
  • Validate predicted off-target sites using targeted deep sequencing (e.g., GUIDE-seq or CIRCLE-seq) in cell line models.
  • Balance on-target efficiency and off-target risk when selecting guides for multiplex editing experiments.
  • Maintain a versioned database of validated guides and associated off-target profiles for reuse across projects.

Module 7: Data Integration and Multi-Omics Analysis

  • Align single-cell RNA-seq data with bulk WGS to trace clonal origins of transcriptional subpopulations.
  • Integrate methylation (WGBS) and expression data to identify epigenetically regulated genes in disease phenotypes.
  • Use WGS-confirmed variants to filter false positives in exome-based association studies with overlapping samples.
  • Map structural variants to topologically associating domains (TADs) using Hi-C data to assess regulatory impact.
  • Perform pathway enrichment analysis on gene sets derived from both coding variants and differentially expressed genes.
  • Apply Mendelian randomization frameworks using germline variants as instrumental variables for causal inference.
  • Harmonize coordinate systems across data types (e.g., liftover from hg19 to hg38) with cross-mapping validation.
  • Develop unified sample identifiers and metadata schema to enable cross-assay querying in data lakes.

Module 8: Regulatory Compliance and Data Governance

  • Classify genomic data under HIPAA, GDPR, or CCPA based on identifiability and implement role-based access controls accordingly.
  • Encrypt raw sequencing data at rest and in transit using FIPS-validated cryptographic modules.
  • Establish data use agreements (DUAs) with collaborators specifying permitted analyses and redistribution restrictions.
  • Implement audit logging for all data access and modification events using centralized SIEM tools.
  • Design de-identification pipelines that remove direct identifiers and suppress rare variant combinations that could re-identify individuals.
  • Obtain IRB approval for secondary analysis of public datasets when combining with internal data for novel hypotheses.
  • Document data provenance from sample collection through analysis using W3C PROV standards for regulatory submissions.
  • Conduct annual security assessments and penetration testing on bioinformatics infrastructure hosting human genomic data.

Module 9: Scalable Workflow Orchestration and Reproducibility

  • Adopt WDL, Nextflow, or Snakemake to define modular, reusable workflows with explicit input/output specifications.
  • Deploy workflow execution engines (e.g., Cromwell, Tower) on Kubernetes clusters for dynamic resource allocation.
  • Integrate workflow versioning with Git tags and container image digests to ensure exact reproducibility.
  • Configure retry policies and error handling for tasks that fail due to transient resource contention.
  • Monitor pipeline performance using metrics such as task runtime, CPU/memory utilization, and I/O throughput.
  • Implement caching of intermediate results to avoid redundant computation during iterative development.
  • Standardize input JSON templates across projects to reduce configuration errors in production runs.
  • Enforce workflow validation through schema checks and pre-execution dry runs in staging environments.